Vistagen Therapeutics, Inc. Common Stock AGM 2026

Good morning, ladies and gentlemen. I am Jessica Haskell, associate general counsel and corporate secretary of VistaGen Therapeutics. Welcome to our 2026 annual meeting of stockholders. We chose to host this meeting through a virtual webinar platform so that every stockholder can join regardless of their physical location. Thank you for being here today. Displayed on your screen is the agenda for today's meeting. As you can see, the meeting will be brief and cover only three business items. If you have a question or comment related to a specific business item on the agenda, you may submit it at any time during the meeting by clicking on the message icon located in the upper right-hand corner of your screen. Please note, as is customary, only questions specifically related to the business items on the agenda will be addressed.

Should you have a question that is not related to a business item on today's agenda, you may submit it to us directly using the contact page of our website at www.vistagen.com. Registered stockholders may still vote during the formal portion of today's meeting by clicking on the vote icon located in the upper right-hand corner of your screen. You are a registered stockholder if you held VistaGen common stock in your own name at our transfer agent, Computershare, as of July 22nd, 2026, which was the record date for this meeting, and used your Computershare issue control number to join today's meeting. Please note, this meeting is being recorded. That said, no one attending is permitted to record the meeting themselves by audio recording device or otherwise, or distribute any part of a recording in any fashion whatsoever.

It is now my pleasure to turn the meeting over to Mr. Jon S. Saxe, chair of the board of directors of VistaGen Therapeutics, to call the meeting to order.

Thank you, Jon. We received proxies to vote more than one-third of the shares entitled to vote at this meeting. In accordance with the company's bylaws, this constitutes a quorum for the meeting. A list of all registered stockholders as of the record date for this meeting has been compiled and certified by the Inspector of Election. A copy of the notice of the meeting, which was mailed to stockholders on or about July 31, 2026, as well as copies of the proxy statement for this meeting and the company's annual report on Form 10-K for its fiscal year ended March 31, 2026, are available for inspection on the virtual meeting platform. As such, this meeting is now declared lawfully and properly convened. Most stockholders have already voted by way of proxy.

If you entered this virtual meeting as a stockholder and not a guest and have not voted yet or you'd like to vote today, you can do so at any time before voting closes. If you've already voted by proxy and don't want to change your vote, there's no need to vote again online. Once voting ends, the Inspector of Election will tabulate the votes. The votes will not be tabulated until after each of the proposals on the agenda has been introduced and you've had the opportunity to vote on each one. The first item on the agenda is the election of directors. The company's restated articles of incorporation, as amended, do not authorize cumulative voting. Therefore, balloting will take place without cumulative voting.

The four nominees who receive the highest number of votes will be elected as directors of the company for a one-year term, or until her or his respective successor is duly elected and qualified. As this meeting was properly convened by the company, I will ask a member of management to place into nomination the Board of Director nominees.

I would like to nominate the following persons to serve as directors of the company for one-year terms ending upon the company's next annual meeting of stockholders, or until her or his successor is duly elected and qualified: Ann Cunningham, Dr. Doug Williamson, Jon S. Saxe, and Shawn Singh.

Thanks, Nick. May I have a second to these nominations?

I second the motion. Thank you, Josh.

The following persons have been nominated for election as directors of the company, each to serve for a one-year term ending upon our next annual meeting of stockholders, or until her or his successor is duly elected and qualified: Ann Cunningham, Dr. Doug Williamson, Jon S. Saxe, and Shawn Singh. The election of directors will now be put to a vote. The polls will remain open regarding the election of directors until after the introduction of the remaining business items on the agenda. Any registered stockholder who wishes to vote online may do so now. The next item on the agenda is an advisory vote on the compensation paid to our named executive officers, which we also refer to as Say on Pay.